Optibrium, a leading developer of software and AI solutions for drug discovery and molecular design, today announced the appointment of James Halle as Chief Commercial Officer (CCO). James brings extensive software experience in the pharma industry and will guide the commercial success of the company. With 20 years’ experience in business leadership, James will be responsible for driving global sales, marketing and customer success activities.
As CCO, he will manage Optibrium’s commercial team whilst working closely with senior leadership to develop and deliver the Company’s product commercialisation strategy. James joins Optibrium from Cytel, a clinical trials services and software business, where as the Global Head of Product Growth, he led the software division’s global commercial team, delivering innovative products to market and driving customer adoption. His experience moving from individual software sales to enterprise solutions at Cytel will help drive the growth of Optibrium’s new cloud-based StarDropTM, CerellaTM and SemetaTM discovery platforms.
Prior to Cytel, James held a range of leadership positions at IQVIA spending the final three years as Director of Global Technology Sales heading a large team across EMEA/APAC/LATAM and the US. James’ wealth of experience in software account management at companies including IBM and LexisNexis brings a fresh perspective to achieve Optibrium’s growth targets. Dr.
Matt Segall, CEO, Optibrium, said: “We are del.